Growth Metrics

Moderna (MRNA) Asset Utilization Ratio (2019 - 2025)

Moderna (MRNA) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.16 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 24.99% to 0.16 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.16 through Dec 2025, down 24.99% year-over-year, with the annual reading at 0.15 for FY2025, 26.11% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.16 at Moderna, down from 0.18 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.86 in Q1 2022, with the low at 0.16 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.47, with a median of 0.4 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio soared 1173.58% in 2021, then plummeted 51.35% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.81 in 2021, then decreased by 8.41% to 0.74 in 2022, then plummeted by 51.27% to 0.36 in 2023, then plummeted by 41.43% to 0.21 in 2024, then decreased by 24.99% to 0.16 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.16, 0.18, and 0.25 for Q4 2025, Q3 2025, and Q2 2025 respectively.